The honor recognizes Lipkin's technical achievements in spearheading the development of novel technologies for infectious disease diagnosis, surveillance, and discovery, in service of public health.
Oregon confirms its first human bird flu case, the latest in dozens of cases in the U.S. this year. Experts discuss the symptoms and how to prevent getting sick.
The award recognizes Lipkin’s decades of significant contributions to public health and the identification, prevention, and treatment of infectious disease outbreaks.
On Jan. 1, 2020, public health officials in the U.S. heard about a strange new virus in China. They didn't know what it was, but at Columbia University, Dr. Ian Lipkin was already nervous.
Scientists CII have created a next-generation sequencing (NGS) technology that employs oligonucleotides (oligos)—short single strands of synthetic DNA—as bait for relevant targets of detection.
